Cargando…
Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma
Leiomyosarcomas are rare mesenchymal neoplasms characterized by a smooth muscle differentiation pattern. Due to the extremely poor prognosis in patients, the development of novel chemotherapeutic regimens remains critically important. In this study, multiple leiomyosarcoma cell lines, SK-UT1, SK-LMS...
Autores principales: | De Carvalho Fischer, Cynthia, Hu, Yue, Morreale, Michael, Lin, Wan Ying, Wali, Akhil, Thakar, Maya, Karunasena, Enusha, Sen, Rupashree, Cai, Yi, Murphy, Lauren, Zahnow, Cynthia A., Keer, Harold, Thakar, Manjusha, Ahuja, Nita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922404/ https://www.ncbi.nlm.nih.gov/pubmed/29721210 http://dx.doi.org/10.18632/oncotarget.25056 |
Ejemplares similares
-
A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
por: Thakar, Manjusha, et al.
Publicado: (2018) -
Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
por: Thakar, Manjusha, et al.
Publicado: (2020) -
Epigenetic signatures differentiate uterine and soft tissue leiomyosarcoma
por: Hasan, Nesrin M., et al.
Publicado: (2021) -
Postauricular Leiomyosarcoma: A Case Report and Literature Review
por: Samal, Dillip, et al.
Publicado: (2013) -
The Dynamic Exome: acquired variants as individuals age
por: Bavarva, Jasmin H., et al.
Publicado: (2014)